Table 2 Clinical characteristics of the patients according to the presence or absence of endoscopic Barrett's esophagus.
| Â | Endoscopic BE | Â | |
|---|---|---|---|
| Â | Negative (n = 94) | Positive (n = 69) | P-value |
Patients profiles | Â | Â | Â |
   Age |  |  |  |
   median; range (years) | 60; 23–80 | 60; 30–77 | 0.8825* |
   Sex |  |  |  |
   Female (%) | 48 (51.1) | 32 (46.4) | 0.5542** |
   BMI |  |  |  |
   median; range | 24.1; 19.2–39.7 | 25.8; 19.2–43.6 | 0.1354* |
Endoscopic results | Â | Â | Â |
   Hiatal hernia (%) | 11 (11.7) | 30 (43.5) | <0.0001** |
   Erosive esophagitis (%) | 13 (13.8) | 21 (30.4) | 0.0099** |
Abdominal surface area | Â | Â | Â |
   VAT (cm2) | 97.45 (19.9–514.2) | 120.2 (27.6–398.8) | 0.0089* |
   SAT (cm2) | 158.15 (34.5–428.7) | 180.4 (35.2–484.8) | 0.3169* |
Circulating factors secreted from adipocytes | Â | Â | Â |
   Leptin (ng/mL) | 9.45 (2.5–27.6) | 12.15 (2.7–26.4) | 0.5058* |
   Adiponectin (μg/mL) | 7.9 (3.2–21.4) | 5.6 (3.2–12.5) | 0.0089* |
Other laboratory parameters | Â | Â | Â |
   AST (U/L) | 24 (12–112) | 27 (12–204) | 0.0789* |
   ALT (U/L) | 30 (4–198) | 32 (11–258) | 0.0645* |
   CHE (U/L) | 341 (208–719) | 372 (198–545) | 0.0225* |
   HDL (mg/dL) | 57 (23–106) | 50 (28–93) | 0.1158* |
   LDL (mg/dL) | 125.5 (40–202) | 125 (61–241) | 0.7548* |
   TG (mg/dL) | 120 (50–524) | 145 (52–809) | 0.1076* |
   HOMA-R | 2.444 (0.578–26.929) | 3.184 (1.102–13.743) | 0.3538* |